Opening book details…
About this Medicine article
Open-Label Phase II Trial of Amprenavir, Abacavir, and Fixed-Dose Zidovudine/Lamivudine in Newly and Chronically HIV-1–Infected Patients by Kost, Rhonda G.; Hurley, Arlene; Zhang, Linqi; Vesanen, Mika; Talal, Andrew; Furlan, Scott; Caldwell, Paul; Johnson, Judy; Smiley, Lynn; Ho, David; Markowitz, Martin is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Kost, Rhonda G.; Hurley, Arlene; Zhang, Linqi; Vesanen, Mika; Talal, Andrew; Furlan, Scott; Caldwell, Paul; Johnson, Judy; Smiley, Lynn; Ho, David; Markowitz, Martin
- Publisher
- Lippincott Williams and Wilkins; Lippincott Williams & Wilkins; Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins; Lippincott Williams & Wilkins Ltd.; Ovid Technologies (Wolters Kluwer Health) (ISSN 1077-9450)
- Published
- 2001
- Field
- Medicine (Health Sciences)